HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Landon, M. B. Search for Related Content PubMed PubMed Citation Articles by Landon, M. B. Social Bookmarking                What's this?

The National Institute of Child Health and Human Development Maternal-Fetal Medicine Unit Network Randomized Clinical Trial in Progress

Standard therapy versus no therapy for mild gestational diabetes

¹ Departments of Obstetrics and Gynecology, Ohio State University, Columbus, Ohio
² George Washington Biostatistics Center, Washington, DC
³ National Institute of Child Health and Human Development, Bethesda, Maryland
⁴ Brown University, Providence, Rhode Island
⁵ University of Texas at Galveston, Galveston, Texas

Address correspondence and reprint requests to Mark B. Landon, MD, The Ohio State University, College of Medicine, Means Hall, 5th Floor, 1654 Upham Dr., Columbus, OH 43210-1228. E-mail: landon.1@osu.edu

Abbreviations: GDM, gestational diabetes mellitus • MFMU, Maternal-Fetal Medicine Unit

The first 300 words of the full text of this article appear below.

	INTRODUCTION

 
It is recognized that women with gestational diabetes mellitus (GDM) who have significantly elevated fasting blood glucose levels are at increased risk for fetal macrosomia and perinatal morbidity if treatment is not provided (1,2). The association of milder forms of GDM with perinatal morbidity and mortality remains unclear, primarily because the condition is often confounded with other risk factors such as maternal obesity, age, and parity. Screening for GDM is recommended for most pregnant women, yet it is unknown whether there is a benefit to the identification and treatment of mild carbohydrate intolerance during pregnancy (3,4). The present report is an update of our previous description of a current ongoing randomized treatment trial for mild GDM (5). A randomized clinical trial of women with mild GDM (fasting glucose <95 mg/dl) is being undertaken that compares perinatal outcomes in those receiving diet therapy and insulin as required versus those randomized to no specific treatment. This study aims to clarify whether there is utility in identifying and treating women with a normal fasting glucose level who meet standard criteria for GDM. We plan to compare perinatal outcomes in women who have been randomized to diet and/or insulin therapy with women who have been randomized to no specific treatment. A randomized treatment trial of mild GDM will clarify whether identification and treatment of mild GDM reduce perinatal morbidity. This information will assist in determining appropriate thresholds for the treatment of GDM.

	BACKGROUND AND STUDY RATIONALE—

 
Overall, with broader identification and aggressive treatment, perinatal mortality rates associated with GDM appear to be similar to the nondiabetic population (1). Several analyses of 20 years ago did document an increased stillbirth rate for GDM pregnancies that would qualify as preexisting diabetes according to World Health Organization criteria (. . . [Full Text of this Article]

	STUDY DESIGN—

 

	STATISTICAL CONSIDERATIONS—

 

	SUMMARY—

 

	APPENDIX

 

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				T. A. Hillier, K. K. Vesco, K. L. Pedula, T. L. Beil, E. P. Whitlock, and D. J. Pettitt Screening for Gestational Diabetes Mellitus: A Systematic Review for the U.S. Preventive Services Task Force Ann Intern Med, May 20, 2008; 148(10): 766 - 775. [Abstract] [Full Text] [PDF]

				The HAPO Study Cooperative Research Group Hyperglycemia and Adverse Pregnancy Outcomes N. Engl. J. Med., May 8, 2008; 358(19): 1991 - 2002. [Abstract] [Full Text] [PDF]